Related Articles
The predictive factor for pathological downgrading after prostatectomy in patients with biopsy Gleason score 4+3 or 4+4 prostate cancer
Upgrading and upstaging in prostate cancer: From prostate biopsy to radical prostatectomy
Soluble interleukin-6 receptor to interleukin-6 (sIL‑6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy
Diagnostic performance of a nomogram incorporating cribriform morphology for the prediction of adverse pathology in prostate cancer at radical prostatectomy
No residual tumor in a radical prostatectomy specimen after neoadjuvant hormonal therapy for localized prostate cancer